CA
NZ
UK
AU
IND
US
Stryker (NYSE:SYK) slipped on Tuesday, trading around $280 during the session, after announcing aLeadershiptransition in a filing with the Securities and Exchange Commission dated October 6. Spencer Stiles, currently president and chief operating officer, will become chief executive on January 1, 2027. Kevin Lobo, …
Thermo Fisher Scientific (NYSE:TMO) edged lower on Tuesday, part of a broad pullback in life-science tools stocks within the S&P 500. No company announcement explaining the move was found. The decline mirrored moves at Danaher (NYSE:DHR), Agilent Technologies (NYSE:A), Revvity (NYSE:RVTY) and IQVIA (NYSE:IQV), …
Moderna (NASDAQ:MRNA) tumbled on Tuesday, closing at $187.46, as one of the steeper decliners in the S&P 500. Sources differed on the size of the drop, but all showed a sharp fall. The move was tied to profit-taking after the World Health Organization downgraded …
Illumina (NASDAQ:ILMN) slid on Tuesday, trading around $273.11 during the session, making it one of the more notable decliners in the S&P 500. The move followed a run that had carried the stock to a 52-week high. The drop was characterized as a technical …
IQVIA Holdings (NYSE:IQV) moved lower on Tuesday, falling alongside a cluster of life-science tools and services companies in the S&P 500. No company-specific news was found to explain the decline. Instead, the drug-development services and health-data company traded in line with peers that serve …
Danaher (NYSE:DHR) slipped on Tuesday, joining a broad retreat in life-science tools stocks across the S&P 500. No company announcement explaining the move was found. The conglomerate, which supplies equipment and consumables for biotechnology, life-science research and diagnostics, moved in step with its closest …
DexCom (NASDAQ:DXCM) fell on Tuesday, trading at about $83.39, with no specific catalyst identified for the move. The maker of continuous glucose monitors slid alongside a wide range of health-care stocks, a group that missed out on a broad rally that carried the S&P …
AngioDynamics (NASDAQ:ANGO) will report results for the first quarter of fiscal 2027, which ended August 31, 2026, before the open on Thursday, October 8. The company said so in a September 28 notice and will hold a call at 8:00 a.m. ET. Published consensus, …
Emergent BioSolutions (NYSE:EBS) shares rose roughly 7 percent on October 5, 2026 to about USD 6.78 in published market data, and no company announcement was found for that session. Quotes on October 6, 2026 vary between about USD 7.07 and USD 7.24, so the …
On September 29, 2026 Iovance Biotherapeutics (NASDAQ:IOVA) raised its 2026 total revenue guidance to USD 410 million to USD 420 million from USD 350 million to USD 370 million. Published market data show the shares closing at USD 14.45 against USD 10.99 the prior …
Please wait processing your request...